Joined AI4Path Lab — AI for Pathology Research at OSU
Started a new research position at the AI Lab for Pathology Research (AI4Path) at The Ohio State University, developing next-generation AI foundation models for digital pathology.
☕️About Me
MD candidate and research scientist specializing in RNA biology, the epitranscriptome, and cardiovascular disease. My doctoral work (PhD, The Ohio State University, 2025) revealed how m6A RNA methylation shapes cardiac function, metabolism, and remodeling — using molecular biology, mouse models, nanopore sequencing, and multi-omics approaches.
I am currently completing my MD with core clinical rotations at OSU and conducting AI-driven digital pathology research at the AI4Path lab. My work bridges basic science, translational medicine, and innovation — from mechanistic discoveries in RNA biology to building diagnostic tools powered by machine learning.
I am passionate about entrepreneurship and thrive at the intersection of medicine, engineering, and technology, translating bold ideas into real-world impact.
Interests
- RNA Biology & Epitranscriptomics
- Cardiovascular Research
- Translational Medicine
- Artificial Intelligence
- Business/Entrepreneurship
Education
MD, Doctor of Medicine
The Ohio State University
PhD Biomedical Engineering
The Ohio State University
CORe — Credential of Readiness
Harvard Business School Online
BSc Biomedical Engineering, Summa Cum Laude
Rutgers University
🧬 My Research
My research focuses on the epitranscriptome — specifically how N6-methyladenosine (m6A) RNA methylation regulates gene expression in the heart. During my PhD at The Ohio State University, I used molecular biology, mouse models, nanopore sequencing, and multi-omics to reveal how m6A shapes cardiac function, metabolism, and remodeling in response to stress and disease.
I am currently completing my MD at OSU, where clinical training in internal medicine, surgery, and other specialties deepens my understanding of how basic discoveries translate to patient care. I am also working at the AI Lab for Pathology Research (AI4Path), developing AI foundation models for digital pathology to transform diagnostic workflows.
Please reach out to collaborate 👋
Featured Publications
Recent Publications
(2025).
AIMP3 maintains cardiac homeostasis by regulating the editing activity of methionyl-tRNA synthetase.
Nature Cardiovascular Research, 4(7), pp. 876–890.
(2025).
The cardiac METTL3/m6A pathway regulates the systemic response to Western diet.
JCI Insight, 10(11), pp. e188414.
(2025).
The m6A-binding protein YTHDF3 modulates the cardiac response to stress.
RNA, 31(7), pp. 923–932.
(2024).
Cardiac cryptographers: cracking the code of the epitranscriptome.
European Heart Journal, 45(23), pp. 2034–2036.
(2024).
CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice.
Molecular Therapy: The Journal of the American Society of Gene Therapy, 32(10), pp. 3683–3694.
Recent & Upcoming Talks
Recent News
New Paper: AIMP3 in Cardiac Homeostasis — Nature Cardiovascular Research
Published in Nature Cardiovascular Research: AIMP3 maintains cardiac homeostasis by regulating the editing activity of methionyl-tRNA synthetase.
New Paper: YTHDF3 Modulates Cardiac Response to Stress — RNA Journal
Published in RNA: The m6A-binding protein YTHDF3 modulates the cardiac response to stress, identifying a new layer of post-transcriptional regulation in heart disease.
PhD Completed — Biomedical Engineering, The Ohio State University
Successfully defended my doctoral thesis on RNA modifications and the epitranscriptome in cardiac homeostasis. Awarded PhD in Biomedical Engineering from The Ohio State University.
New Paper: Cardiac METTL3/m6A Pathway and Systemic Response to Western Diet — JCI Insight
Our latest study published in JCI Insight reveals how the cardiac METTL3/m6A epitranscriptomic pathway regulates the systemic metabolic response to a Western diet.